Correlation Between Purple Biotech and Synaptogenix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Synaptogenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Synaptogenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Synaptogenix, you can compare the effects of market volatilities on Purple Biotech and Synaptogenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Synaptogenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Synaptogenix.

Diversification Opportunities for Purple Biotech and Synaptogenix

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Purple and Synaptogenix is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Synaptogenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synaptogenix and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Synaptogenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synaptogenix has no effect on the direction of Purple Biotech i.e., Purple Biotech and Synaptogenix go up and down completely randomly.

Pair Corralation between Purple Biotech and Synaptogenix

Given the investment horizon of 90 days Purple Biotech is expected to generate 6.34 times more return on investment than Synaptogenix. However, Purple Biotech is 6.34 times more volatile than Synaptogenix. It trades about 0.24 of its potential returns per unit of risk. Synaptogenix is currently generating about 0.11 per unit of risk. If you would invest  297.00  in Purple Biotech on September 4, 2024 and sell it today you would earn a total of  543.00  from holding Purple Biotech or generate 182.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Purple Biotech  vs.  Synaptogenix

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Purple Biotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Purple Biotech unveiled solid returns over the last few months and may actually be approaching a breakup point.
Synaptogenix 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Synaptogenix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Synaptogenix is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Purple Biotech and Synaptogenix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and Synaptogenix

The main advantage of trading using opposite Purple Biotech and Synaptogenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Synaptogenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synaptogenix will offset losses from the drop in Synaptogenix's long position.
The idea behind Purple Biotech and Synaptogenix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity